Trade Amgen ^AMGN

Amgen (NASDAQ:AMGN) Issues Earnings Results - Markets Daily

Amgen (NASDAQ:AMGN) Releases Earnings Results, Beats Expectations By $0.53 EPS - Markets Daily

Amgen Q4 Earnings Call Highlights | MarketBeat

U.S. Market Brief: Tech Stocks Weigh on Indices; AMD Declines in After-Hours Trading While Super Micro Soars

Amgen (NASDAQ:AMGN) Issues Quarterly Earnings Results, Beats Expectations By $0.55 EPS

Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025

Amgen quarterly results beat Street estimates on higher sales, lower tax rate

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS | Morningstar

Amgen Lawsuit Over 340B Discounts As Stock Trades Near Valuation Targets

Amgen Inc. Q4 Profit Rises

Jim Cramer on Amgen: "The Biotech Really Impressed Me With a Very Strong Pipeline"

Amgen Q4 25 Earnings Conference Call At 4:30 PM ET

AlphaQuest LLC Makes New Investment in Amgen Inc. $AMGN

Will Exiting Rocatinlimab Reshape Amgen's (AMGN) Immunology Focus and Broader R&D Narrative? - Simply Wall St News

Amgen News | Markets Insider

Steve Jobs' Son Enters Venture Capital Field, Raises $200M to Combat Cancer

Regulatory clarity lifts Aquestive despite CRL for Anaphylm | BioWorld

Principal Financial Group Inc. Lowers Holdings in Amgen Inc. $AMGN

United Community Bank Sells 3,842 Shares of Amgen Inc. $AMGN

Amgen quits Kyowa Kirin deal, returns rocatinlimab | BioWorld

Kyowa Kirin (TSE:4151) Regains Rocatinlimab Control Is Its R&D Strategy Entering a New Phase? - Simply Wall St News

Amgen (AMGN) Reports Q4: Everything You Need To Know Ahead Of Earnings

Amgen Refocuses Pipeline As Rocatinlimab Exit Reshapes Dermatology Outlook

Atle Fund Management AB Decreases Holdings in Amgen Inc. $AMGN

Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities - Simply Wall St News

Alpha Cubed Investments LLC Reduces Holdings in Amgen Inc. $AMGN

Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views

Amgen (NASDAQ:AMGN) Reaches New 1-Year High - Should You Buy? - Stock Observer

IgG4-Related Disease Market Size is Projected to grow at a CAGR of 34.60% by 2034, estimates DelveInsight

UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves

Amgen Inc. $AMGN Shares Sold by New York State Common Retirement Fund

AE Wealth Management LLC Purchases 18,798 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by JSF Financial LLC - Daily Political

Amgen Inc. $AMGN Shares Sold by Great Lakes Advisors LLC - Daily Political

Amgen Inc. $AMGN Stake Increased by Fidelis Capital Partners LLC - Daily Political

Amgen Faces 340B Legal Challenge As Stock Trades Near Analyst Views

Amgen (NASDAQ:AMGN) Sets New 12-Month High - What's Next?

Amgen Inc. $AMGN is Federated Hermes Inc.'s 10th Largest Position

Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp

Amgen Lawsuit Over 340B Discounts Puts Pricing And Policy In Focus

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial

Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains

Amgen (AMGN) to Release Quarterly Earnings on Tuesday

Bernstein Calls 2026 a "Waiting Year" for Amgen's (AMGN) MariTide

Mutual of America Capital Management LLC Sells 3,290 Shares of Amgen Inc. $AMGN - Daily Political

15 Best S&P 500 Dividend Stocks to Buy in 2026

Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials

Will 340B Lawsuit Over Drug Discounts Shift Amgen's (AMGN) Access Strategy And Investment Narrative?

Whittier Trust Co. Acquires 39,111 Shares of Amgen Inc. $AMGN

Investment House LLC Has $7.31 Million Stake in Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by AMF Tjanstepension AB

UniSuper Management Pty Ltd Acquires 6,911 Shares of Amgen Inc. $AMGN

Amgen Inc. $AMGN Shares Sold by Strs Ohio | MarketBeat

Modera Wealth Management LLC Sells 2,434 Shares of Amgen Inc. $AMGN - Stock Observer

Assessing Amgen (AMGN) Valuation After The New Sagebrush 340B Lawsuit

Lockheed Martin Investment Management Co. Invests $2.62 Million in Amgen Inc. $AMGN

CFOs On the Move: Week ending Jan. 23

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer

Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?

Amgen Faces 340B Lawsuit Spotlighting Drug Pricing And Investor Risks

U.S. stock market surges as Russell 2000 hits record: Russell 2000 index hits record high, up 1.25%: U.S. stock market surges as small caps lead the broad rally - Dow also rises on stronger GDP - The Economic Times

Rakuten Investment Management Inc. Makes New Investment in Amgen Inc. $AMGN - Markets Daily

Amgen (NASDAQ:AMGN) Hits New 1-Year High - Here's Why - Daily Political

Joel Isaacson & Co. LLC Purchases 1,800 Shares of Amgen Inc. $AMGN - Markets Daily

Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies

Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - Simply Wall St News

Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.52

Arkadios Wealth Advisors Increases Stock Holdings in Amgen Inc. $AMGN

Bernstein downgrades Amgen (AMGN) to a Hold | Markets Insider

Sanford C. Bernstein Downgrades Amgen (NASDAQ:AMGN) to Market Perform

Seizert Capital Partners LLC Trims Stock Position in Amgen Inc. $AMGN

Vaughan David Investments LLC IL Cuts Holdings in Amgen Inc. $AMGN - Daily Political

Tradewinds LLC. Makes New $988,000 Investment in Amgen Inc. $AMGN

Royal Fund Management LLC Cuts Holdings in Amgen Inc. $AMGN

AMGN: Obesity And Cardiovascular Pipeline Will Support Long-Term Upside Potential

3,785 Shares in Amgen Inc. $AMGN Bought by Campbell & CO Investment Adviser LLC

Allstate Corp Has $5.54 Million Stock Position in Amgen Inc. $AMGN

Tradewinds LLC. Purchases New Stake in Amgen Inc. $AMGN - Daily Political

Amgen Inc. (NASDAQ:AMGN) Receives $339.45 Average Target Price from Analysts - Stock Observer

I talked to many health CEOs out West and see big things for drug stocks

DISCO Oncology Pact And MariTide Obesity Data Might Change The Case For Investing In Amgen (AMGN)

Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company

Amgen Inc. $AMGN Stock Position Cut by QRG Capital Management Inc.

WoodTrust Financial Corp Sells 588,232 Shares of Amgen Inc. $AMGN - Daily Political

Assessing Amgen (AMGN) Valuation As Shares Track Close To Analyst Targets

Nwam LLC Buys 1,576 Shares of Amgen Inc. $AMGN

Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Is Amgen (AMGN) Still Attractive After A 26% One Year Share Price Gain

Amgen Inc. (AMGN): A Bull Case Theory

Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial

Amgen Inc. $AMGN Shares Acquired by Global Wealth Management Investment Advisory Inc.

Amgen Inc. $AMGN Stock Holdings Lowered by Cullinan Associates Inc. - Daily Political

Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study

Amgen CEO: weight loss drug can address 'patient persistence issue'

Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Yahoo News Canada